These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26174899)

  • 41. Intravenous immune globulin for multiple sclerosis.
    Tecnologica MAP Suppl; 1998 Aug; ():3-5. PubMed ID: 10342975
    [No Abstract]   [Full Text] [Related]  

  • 42. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.
    Yu Z; Lennon VA
    N Engl J Med; 1999 Jan; 340(3):227-8. PubMed ID: 9895405
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation].
    Winston DJ; Ho WG; Lin GH; Bartoni K; Budinger MD; Gale RP; Champlin RE
    Immun Infekt; 1985 Nov; 13(6):296-301. PubMed ID: 3000923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects and side effects of intravenous gamma globulin I: the problem of immune complex formation].
    Tilz GP; Nydegger U
    Wien Med Wochenschr; 1991; 141(13):301-3. PubMed ID: 1926879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Gelfand EW
    N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
    [No Abstract]   [Full Text] [Related]  

  • 47. The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin.
    Cocito D; Serra G; Falcone Y; Paolasso I
    J Peripher Nerv Syst; 2011 Jun; 16(2):150-2. PubMed ID: 21692916
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravenous immune globulin for recurrent fetal loss.
    Tecnologica; 1995 Nov; ():7-8. PubMed ID: 10168306
    [No Abstract]   [Full Text] [Related]  

  • 49. Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: successful treatment with intravenous gamma globulin.
    Pearlman SA; Meek RS; Cowchock FS; Smith JB; McFarland J; Aster RH
    Am J Perinatol; 1992; 9(5-6):448-51. PubMed ID: 1418154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous immune globulin for multiple sclerosis.
    Tecnologica; 1995 May; ():10. PubMed ID: 10168292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subcutaneous IgG replacement therapy is safe and well tolerated in lung transplant recipients.
    Shankar T; Gribowicz J; Crespo M; Silveira FP; Pilewski J; Petrov AA
    Int Immunopharmacol; 2013 Apr; 15(4):752-5. PubMed ID: 23499641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innovative uses of intravenous immunoglobulins in clinical hematology. Symposium. December 5, 1986, San Francisco, California. Proceedings.
    Am J Med; 1987 Oct; 83(4A):1-56. PubMed ID: 3118702
    [No Abstract]   [Full Text] [Related]  

  • 55. Respiratory syncytial virus immune globulin intravenous (human) receives marketing approval in Canada.
    Langley JM
    Can Fam Physician; 1998 Jan; 44():113. PubMed ID: 9481469
    [No Abstract]   [Full Text] [Related]  

  • 56. [Renal tolerance to intravenous polyvalent human immunoglobulins (IgIV) in neurological disorders].
    Item C; Verny M; Leger JM; Eymard B; Petitclerc T
    Presse Med; 1995 Jun; 24(21):1005. PubMed ID: 7667218
    [No Abstract]   [Full Text] [Related]  

  • 57. Important drug information: immune globulin intravenous (human).
    Epstein JS; Gaines A; Kapit R; Pierce R; Potter R; Varricchio F
    Int J Trauma Nurs; 1999; 5(4):139-40. PubMed ID: 10661146
    [No Abstract]   [Full Text] [Related]  

  • 58. Quantifying the thrombogenic potential of human plasma-derived immunoglobulin products.
    Germishuizen WA; Gyure DC; Stubbings D; Burnouf T
    Biologicals; 2014 Sep; 42(5):260-70. PubMed ID: 25096922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous immune globulin for recurrent spontaneous abortion.
    Tecnologica MAP Suppl; 1998 May; ():11-3. PubMed ID: 10184996
    [No Abstract]   [Full Text] [Related]  

  • 60. [Indication for use and mechanisms of action of intravenous immune globulin in autoimmune diseases].
    Cohen AD; Shoenfeld Y
    Harefuah; 1995 Aug; 129(3-4):123-7. PubMed ID: 8543238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.